[Therapeutic effect of the latest extracorporal elimination procedure (Prometheus treatment) in acute liver failure caused by intoxication].

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Orvosi Hetilap

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 17932004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results.

  2006cited by this paper
• Hepatocyte transplantation in an acute liver failure due to mushroom poisoning.

  2006cited by this paper
• Journey from hepatocyte transplantation to hepatic stem cells: a novel treatment strategy for liver diseases.

  2006cited by this paper
• Fulminant Hepatic Failure Bridged to Liver Transplantation with a Molecular Adsorbent Recirculating System: A Single-Center Experience

  2006cited by this paper
• Removal selectivity of Prometheus: a new extracorporeal liver support device.

  2006cited by this paper
• AASLD position paper: The management of acute liver failure

  2005cited by this paper
• In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation.

  2005cited by this paper
• The Prometheus® Device for Extracorporeal Support of Combined Liver and Renal Failure

  2005cited by this paper
• Detoxifying Capacity and Kinetics of Prometheus® – A New Extracorporeal System for the Treatment of Liver Failure

  2005cited by this paper
• Clinical Application of Bioartificial Liver Support Systems

  2004cited by this paper
• Value of albumin dialysis therapy in severe liver insufficiency

  2004cited by this paper
• Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus)

  2003cited by this paper
• Prometheus--a new extracorporeal system for the treatment of liver failure.

  2003cited by this paper
• Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson's disease

  2002cited by this paper
• Selective plasma filtration for treatment of fulminant hepatic failure induced by d-galactosamine in a pig model

  2002cited by this paper
• The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers.

  2002cited by this paper
• Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study

  2002cited by this paper
• Extracorporeal perfusion for the treatment of acute liver failure.

  2000cited by this paper
• A Single Institution's Experience (1982–1999) with Plasma-Exchange Therapy in Patients with Fulminant Hepatic Failure

  2000cited by this paper
• Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances.

  1999cited by this paper
• Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

  1988cited by this paper
• Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane.

  1978cited by this paper
• Acute hepatocellular failure. A study of 17 patients treated with exchange transfusion.

  1972cited by this paper

• Artificial liver support system in treatment of liver failure after acute poisoning.

  2011cites this paper
• Emergent right lobe adult‐to‐adult living‐donor liver transplantation for high model for end‐stage liver disease score severe hepatitis

  2010cites this paper
• Severe acetaminophen poisoning treated with a fractionated plasma separation and absorption system: A case report

  2009cites this paper
• Extracorporeal Liver Support Therapy With Prometheus in Patients With Liver Failure in the Intensive Care Unit

  2009cites this paper